AMPHIPROTECH
Live / Registered — Registered (as of 05 Mar 2024)
What this means for you
Registered since 05 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79360545
- Registration number
- 7318395
- Mark type
- Stylized text
- Filed
- 30 Nov 2022
- Published for opposition
- 19 Dec 2023
- Registered
- 05 Mar 2024
- Attorney of record
- David M. Perry
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of liver diseases; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the treatment of infectious diseases, blood disorders, immune system related diseases, tumours, thyroid disease, cardiovascular and cerebrovascular diseases, inflammation and cancer; Biological preparations for medical purposes for the treatment of cancer, insomnia and heart disease; Biological preparations for medical purposes for the prevention and treatment of liver diseases; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs, namely, insulin for the treatment of diabetes for medical purposes; Pharmaceutical preparations, namely, analgesics, antibiotics and aspirin; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Medicines in form of tablet form for the treatment of cancer, insomnia and heart disease; Medicines in form of tablet form for the prevention and treatment of liver diseases; Medicines in form of tablet form for the prevention and treatment of respiratory system disorders; Medicines in form of tablet form for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines in form of tablet form for the prevention and treatment of gastro-intestinal diseases; Medicines in form of tablet form for the prevention and treatment of immune system related diseases and disorders; Medicines in form of tablet form for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Biochemical medicines for the treatment of cancer, insomnia and heart disease; Biochemical medicines for the prevention and treatment of liver diseases; Biochemical medicines for the prevention and treatment of respiratory system disorders; Biochemical medicines for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Biochemical medicines for the prevention and treatment of gastro-intestinal diseases; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Capsules for medicines for the treatment of cancer, insomnia and heart disease; Capsules for medicines for the prevention and treatment of liver diseases; Capsules for medicines for the prevention and treatment of respiratory system disorders; Capsules for medicines for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes; Capsules for medicines for the prevention and treatment of gastro-intestinal diseases; Capsules for medicines for the prevention and treatment of immune system related diseases and disorders; Capsules for medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Injectable medicinal solutions, namely, dermal fillers; Injectable medicinal solutions, namely, injectable contraceptives; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purposes
Owner
Prosecution history
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2023 — NOTIFICATION PROCESSED BY IB
- 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Dec 2023 — PUBLISHED FOR OPPOSITION
- 29 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Nov 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED